The presence of IGF-1 enhances the proliferation rate of MM cells and promotes angiogenesis within the bone marrow by upregulating VEGF production via the MEK/ERK signaling pathway [98,99]. This evidence concerns the gene IGF1 and Miyoshi myopathy.